The global Nuclear Medicine Equipment Market is expanding as hospitals, diagnostic imaging centers, cancer treatment centers, and other healthcare providers increasingly adopt advanced technologies for functional imaging, disease diagnosis, and targeted treatment planning. The Nuclear Medicine Equipment Market size is expected to reach US$ 9.58 Billion by 2033 from US$ 7.0 Billion in 2025, registering a CAGR of 4.00% during 2026–2033.
Growing prevalence of cancer and cardiovascular diseases, an expanding elderly population, increasing demand for precise medical diagnosis, technological advancements in PET and SPECT systems, and development of hybrid imaging technologies are supporting market expansion. Improvements in image quality, shorter scan durations, digital workflows, and the growing role of molecular imaging and theranostics are further strengthening demand for nuclear medicine equipment.
Market Overview
The Nuclear Medicine Equipment Market includes equipment used for functional and molecular imaging and related nuclear medicine procedures. These systems support the diagnosis and management of oncology, cardiology, neurology, orthopedics, thyroid disorders, and other medical conditions by providing information beyond conventional anatomical imaging.
The market is segmented by product into imaging modalities, including PET, SPECT, and gamma imaging, and non-imaging modalities, including GM counters and dose calibrators. By therapeutic area, the market includes oncology, cardiology, neurology, orthopedics, thyroid, and other therapeutic areas. By dimension, it is divided into 2D and 3D, while end users include hospitals, diagnostic imaging centers, cancer treatment centers, and other end users. Imaging modalities, oncology, 3D systems, and diagnostic imaging centers held the largest shares in their respective segments in 2025.
Check valuable insights in the Nuclear Medicine Equipment Market report. You can easily get a sample PDF of the report – https://www.businessmarketinsights.com/sample/BMIPUB00033653
What is driving the Nuclear Medicine Equipment Market?
The rising prevalence of cancer and cardiovascular diseases is a major factor supporting demand for nuclear medicine equipment. Increasing patient volumes and the need for earlier disease detection are encouraging hospitals and diagnostic centers to expand PET and SPECT imaging capabilities. Nuclear medicine can provide metabolic and molecular information that supports disease characterization, treatment planning, and patient monitoring.
The expanding elderly population and increasing prevalence of chronic diseases are creating additional demand. Healthcare providers are also investing in advanced diagnostic infrastructure as precision medicine, molecular imaging, and targeted treatment approaches become more important.
Key Market Trends
- Increasing adoption of PET and SPECT imaging systems.
- Growing use of hybrid nuclear imaging technologies.
- Rising demand for 3D imaging capabilities.
- Increasing integration of digital workflows and advanced software.
- Growing adoption of nuclear medicine in precision oncology.
- Rising development of theranostics and new therapeutic radiotracers.
- Increasing expansion of diagnostic imaging and cancer treatment centers.
How are hybrid and advanced imaging technologies shaping the market?
Technological advancements in detector technology, PET and SPECT systems, hybrid imaging, and image-processing software are improving nuclear medicine performance. Higher image resolution, faster scanning, improved lesion localization, and enhanced workflow connectivity are helping healthcare providers improve diagnostic confidence and operational efficiency.
Hybrid systems that combine functional and anatomical information are also becoming increasingly important. PET/CT and other integrated imaging approaches can provide more comprehensive clinical information and support applications across oncology, cardiology, and neurology.
Global Market Insights
The global Nuclear Medicine Equipment Market spans North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa. Market growth is being influenced by rising chronic disease burden, healthcare infrastructure expansion, adoption of advanced imaging technologies, precision medicine, and growing demand for specialized nuclear medicine services.
- North America: Supported by advanced healthcare infrastructure, strong nuclear medicine capabilities, rising adoption of PET and SPECT, and favorable reimbursement frameworks.
- Europe: Benefiting from established healthcare systems, nuclear medicine expertise, molecular imaging adoption, and increasing focus on precision medicine.
- Asia Pacific: Offering strong growth potential through healthcare infrastructure expansion, rising cancer and cardiovascular disease prevalence, and increasing investment in advanced diagnostic technologies.
- Middle East & Africa: Creating opportunities through healthcare modernization, development of specialized cancer centers, and increasing investment in advanced medical technologies.
- South & Central America: Supported by improving healthcare access, development of diagnostic facilities, and increasing demand for advanced imaging procedures.
Explore Nuclear Medicine Equipment Market Growth in Industry Snippets at: https://www.businessmarketinsights.com/industry-overview/nuclear-medicine-equipment-market
Regional Analysis
North America is expected to grow significantly during the forecast period. The region is supported by advanced healthcare infrastructure, strong research and development activity, increasing adoption of PET and SPECT systems, and expanding use of radiopharmaceuticals for diagnosis and therapy. The US and Canada are important contributors because of established nuclear medicine networks and cancer treatment infrastructure.
Asia Pacific is also creating significant opportunities as healthcare systems expand and governments and private providers invest in advanced diagnostic infrastructure. China, India, Japan, and South Korea are increasing adoption of advanced imaging technologies while developing specialized cancer and nuclear medicine centers.
Which product types are creating new opportunities?
Imaging modalities held the largest share by product in 2025, supported by widespread use of PET, SPECT, and gamma imaging for disease diagnosis and clinical assessment. These systems offer functional imaging capabilities and are increasingly used across oncology, cardiology, neurology, and other therapeutic areas.
Non-imaging modalities, including GM counters and dose calibrators, continue to play an important supporting role in nuclear medicine workflows. Growing nuclear medicine activity and expansion of imaging facilities are creating additional demand for these systems.
Which therapeutic areas are driving demand?
Oncology represented the largest therapeutic area segment in 2025. Rising cancer prevalence, increasing demand for early diagnosis and staging, and growing use of PET imaging in cancer care are supporting continued demand for nuclear medicine equipment.
Cardiology, neurology, orthopedics, and thyroid applications are also creating opportunities. Nuclear imaging can support functional assessment and disease monitoring across these areas, while advances in molecular imaging and radiotracer development are expanding clinical applications.
Market Forecast by 2033
The Nuclear Medicine Equipment Market is expected to grow from US$ 7.0 Billion in 2025 to US$ 9.58 Billion by 2033, registering a CAGR of 4.00% during 2026–2033. The forecast outlook is supported by rising cancer and cardiovascular disease prevalence, population aging, healthcare infrastructure expansion, technological advancements, and growing adoption of precision diagnostic technologies.
What is changing in 2026?
The industry is increasingly moving toward hybrid imaging, AI-supported image analysis, improved workflow automation, and technologies designed to support precision medicine and theranostics. Manufacturers and healthcare providers are focusing on improved image quality, faster processing, greater clinical utility, and better integration of nuclear medicine systems into digital healthcare environments.
Recent developments highlighted in the BMI report include GE HealthCare’s June 2025 presentation of theranostics-enabling solutions at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting, including LesionID Pro from MIM Software with automated zero-click preprocessing and AI-powered capabilities to support physician decision-making and therapy response monitoring. In August 2025, SNMMI announced the launch of its Global Radiopharmaceutical Trial Finder, an AI-powered platform designed to help researchers, clinicians, and patients identify relevant radiopharmaceutical clinical trials.
What are the major investment opportunities?
Investment opportunities are emerging across PET, SPECT, hybrid imaging systems, 3D imaging, AI-enabled software, automated workflows, and technologies supporting precision oncology. Increasing demand for earlier and more accurate diagnosis is encouraging healthcare providers to expand specialized nuclear medicine capabilities.
Emerging markets provide additional opportunities as hospitals, diagnostic imaging centers, and cancer treatment centers expand their capabilities. Continued development of new radiotracers and theranostic applications can also broaden the potential use of nuclear medicine equipment across diagnosis and treatment pathways.
Strategic Analysis
Image quality, system performance, workflow efficiency, integration capabilities, service support, capital requirements, and regulatory compliance will remain important competitive priorities. Manufacturers are focusing on advanced detectors, hybrid imaging platforms, automated workflows, and software solutions that can improve clinical productivity.
The market also faces challenges including high equipment costs, restricted access to radioisotopes, stringent regulatory requirements, specialized facility needs, shortages of qualified personnel, supply-chain disruptions, and reimbursement limitations. Companies that can improve system affordability, operational efficiency, and service accessibility can strengthen their competitive position.
Get Premium Research Report of Nuclear Medicine Equipment Market Size and Growth Report by 2033 at: https://www.businessmarketinsights.com/buy/BMIPUB00033653
Industry News & Developments
Recent developments demonstrate increasing emphasis on AI-enabled nuclear medicine workflows, theranostics, and advanced hybrid imaging.
- In June 2025, GE HealthCare showcased theranostics-enabling solutions at the SNMMI Annual Meeting, including LesionID Pro from MIM Software with automated zero-click preprocessing and AI-powered capabilities.
- In August 2025, SNMMI launched the Global Radiopharmaceutical Trial Finder, an AI-powered platform designed to improve access to radiopharmaceutical clinical trial information.
- In October 2024, Mediso introduced the AnyScan TRIO SPECT/CT TheraMAX at the European Association of Nuclear Medicine meeting for theranostic imaging and radioisotope therapies.
Key Players
The Nuclear Medicine Equipment Market report profiles major companies including:
- GE HealthCare
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- Mirion Technologies, Inc.
- Canon Medical Systems Corporation
- Hermes Medical Solutions
- DOSIsoft SA
- Segami Corporation
- Winkgen Medical Systems GmBH & Co. KG
- Comecer S.P.A
Conclusion
The Nuclear Medicine Equipment Market is positioned for steady growth through 2033 as healthcare providers expand their use of advanced molecular and functional imaging technologies. Rising cancer and cardiovascular disease prevalence, population aging, precision medicine, and healthcare infrastructure development are creating sustained demand.
With the market expected to reach US$ 9.58 Billion by 2033, opportunities are expanding across PET, SPECT, gamma imaging, non-imaging modalities, 2D and 3D systems, oncology, cardiology, neurology, orthopedics, thyroid applications, and specialized healthcare facilities. Continued innovation in hybrid imaging, AI-supported workflows, theranostics, and molecular imaging is expected to remain important to market development.
Trending Related Reports:
- Nuclear Medicine Radiopharmaceuticals Market — Covers diagnostic and therapeutic radiopharmaceuticals used across oncology, cardiology, neurology, hospitals, and diagnostic centers.
- Radiopharmaceuticals Market — Examines diagnostic and therapeutic radiopharmaceutical technologies, isotopes, precision oncology, and nuclear imaging applications.
- Diagnostic Imaging Equipment Market — Covers MRI, CT, ultrasound, X-ray, nuclear imaging, portable systems, and AI-enabled diagnostic technologies.
- Radiation Dose Management Market — Focuses on dose optimization, AI reconstruction, nuclear medicine, radiography, CT, and safer precision diagnostic workflows.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Contact us:
If you have any questions about this report or would like further information, please contact us:
Contact person: Ankit Mathur
Email: sales@businessmarketinsights.com
Phone: +16467917070
